HIV-Associated Myocarditis

Heart Failure Clinics

Volumn 1, Issue 3, 2005, Pages 439-448

  Barbaro, Giuseppe ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; CD4 ANTIGEN; CYTOKINE; IMMUNOGLOBULIN; INDUCIBLE NITRIC OXIDE SYNTHASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

AUTOPSY; B LYMPHOCYTE; BACTERIAL INFECTION; CANDIDA; COCCIDIOIDES IMMITIS; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; COXSACKIE VIRUS B3; CRYPTOCOCCUS NEOFORMANS; CYTOMEGALOVIRUS; DENDRITIC CELL; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DNA HYBRIDIZATION; DRUG EFFICACY; ECHOCARDIOGRAPHY; EPSTEIN BARR VIRUS; HEART INFARCTION; HEART LEFT VENTRICLE; HEART MUSCLE CELL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOLOGY; HISTOPLASMA CAPSULATUM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE; MACROPHAGE; MONOCYTE; MYCOBACTERIUM INTRACELLULARE AVIUM; MYCOBACTERIUM TUBERCULOSIS; MYCOSIS; MYOCARDITIS; PARASITOSIS; PLASMA CELL; PNEUMOCYSTIS CARINII; REVIEW; SENSITIVITY AND SPECIFICITY; ST SEGMENT ELEVATION; TOXOPLASMA GONDII; VIRUS INFECTION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; HIV INFECTIONS; HIV-1; HUMANS; MYOCARDITIS; MYOCARDIUM;

EID: 33646166612     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2005.06.006     Document Type: Review

References (34)

1. Barbaro G., Di Lorenzo G., Grisorio B., et al. Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV positive patients. N Engl J Med 339 (1998) 1093-1099
2. Barbaro G., Di Lorenzo G., Grisorio B., et al. Cardiac involvement in the acquired immunodeficiency syndrome: a multicenter clinical-pathological study. AIDS Res Hum Retroviruses 14 (1998) 1071-1077
3. Herskowitz A., Tzyy-Choou W., Willoughby S.B., et al. Myocarditis and cardiotropic viral infection associated with severe left ventricular dysfunction in late-stage infection with human immunodeficiency virus. J Am Coll Cardiol 24 (1994) 1025-1032
4. Pugliese A., Isnardi D., Saini A., et al. Impact of highly active antiretroviral therapy in HIV-positive patients with cardiac involvement. J Infect 40 (2000) 282-284
5. Bijl M., Dieleman J.P., Simoons M., et al. Low prevalence of cardiac abnormalities in an HIV-seropositive population on antiretroviral combination therapy. J Acquir Immune Defic Syndr 27 (2001) 318-320
6. Nzuobontane D., Blackett K.N., and Kuaban C. Cardiac involvement in HIV-infected people in Yaounde, Cameroon. Postgrad Med J 78 (2002) 678-681
7. Barbaro G., Di Lorenzo G., Soldini M., et al. The intensity of myocardial expression of inducible nitric oxide synthase influences the clinical course of human immunodeficiency virus-associated cardiomyopathy. Circulation 100 (1999) 933-939
8. Beschorner W.E., Baughman K.L., Turnicky R.P., et al. HIV-associated myocarditis: pathology and immunopathology. Am J Pathol 137 (1990) 1365-1371
9. Herskowitz A., Willoughby S.B., Vlahov D., et al. Dilated heart muscle disease associated with HIV infection. Eur Heart J 16 (1995) 50-55
10. Klatt E.C., Nichols L., and Noguchi T.T. Emerging patterns of heart disease in human immunodeficiency virus infection. Hum Pathol 118 (1994) 884-890
11. Klatt E.C. Cardiovascular pathology in AIDS. Adv Cardiol 40 (2003) 23-48
12. Anderson D.W., and Virmani R. Emerging patterns of heart disease in human immunodeficiency virus infection. Hum Pathol 21 (1990) 253-257
13. Oddò D., Casanova M., Acuna G., et al. Acute Chagas's disease (Trypanosomiasis americana) in acquired immunodeficiency syndrome: report of two cases. Hum Pathol 23 (1992) 41-44
14. Sartori A.M., Lopes M.H., Benvenuti L.A., et al. Reactivation of Chagas' disease in a human immunodeficiency virus-infected patient leading to severe heart disease with a late positive direct microscopic examination of the blood. Am J Trop Med Hyg 59 (1998) 784-786
15. Barbaro G., Di Lorenzo G., Grisorio B., et al. Cardiac involvement in the acquired immunodeficiency syndrome: a multicenter clinical-pathological study. AIDS Res Hum Retroviruses 14 (1998) 1071-1077
16. Bowles N.E., Kearney D.L., Ni J., et al. The detection of viral genomes by polymerase chain reaction in the myocardium of pediatric patients with advanced HIV disease. J Am Coll Cardiol 34 (1999) 857-865
17. Shannon R.P., Simon M.A., Mathier M.A., et al. Dilated cardiomyopathy associated with simian AIDS in nonhuman primates. Circulation 101 (2000) 185-193
18. Twu C., Liu Q.N., Popik W., et al. Cardiomyocytes undergo apoptosis in human immunodeficiency virus cardiomyopathy through mitochondrion and death receptor-controlled pathways. Proc Natl Acad Sci U S A 99 (2002) 14386-14391
19. Fiala M., Popik W., Qiao J.-H., et al. HIV-1 induces cardiomyopathy by cardiomyocyte invasion and gp120,Tat, and cytokine apoptotic signaling. Cardiovasc Toxicol 4 (2004) 97-107
20. Herskowitz A., Willoughby S.B., Wu T.C., et al. Immunopathogenesis of HIV-1 associated cardiomyopathy. Clin Immunol Immunopathol 68 (1993) 234-241
21. Johnson H.M., Torres B.A., and Soos J.M. Superantigens: structure and relevance to human disease. Proc Soc Exp Biol Med 212 (1996) 99-109
22. Matsumori A. Cytokines in myocarditis and cardiomyopathy. Curr Opin Cardiol 11 (1996) 302-309
23. Liu Q.N., Reddy S., Sayre J.W., et al. Essential role of HIV-1 infected and cyclooxygenase 2 activated macrophages and T cells in HIV type 1 myocarditis. AIDS Res Hum Retroviruses 17 (2001) 1423-1433
24. Finkel M.S., Oddis C.V., Jacob T.D., et al. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257 (1992) 387-389
25. Yokohama T., Vaca L., Rossen R.D., et al. Cellular basis for the negative inotropic effect of tumor necrosis factor-alpha in the adult mammalian heart. J Clin Invest 92 (1993) 2303-2312
26. Lowenstein C.J., Hill S.L., Lafond-Walker A., et al. Nitric oxide inhibits viral replication in murine myocarditis. J Clin Invest 97 (1996) 1837-1843
27. Saura M., Zaragoza C., McMillan A., et al. An antiviral mechanism of nitric oxide: inhibition of a viral protease. Immunity 10 (1999) 21-28
28. Freeman G.L., Colston J.T., Zabalgoitia M., et al. Contractile depression and expression of proinflammatory cytokines and iNOS in viral myocarditis. Am J Physiol 274 (1998) 249-258
29. Ungureanu-Longrois D., Balligand J.L., Simmons W.W., et al. Induction of nitric oxide synthase activity by cytokines in ventricular myocytes is necessary but not sufficient to decrease contractile responsiveness to beta-adrenergic agonists. Circ Res 77 (1995) 494-502
30. Yoshizumi M., Perrella M.A., Burnett Jr. J., et al. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res 73 (1993) 205-209
31. Barbaro G., Fisher S.D., Giancaspro G., et al. HIV-associated cardiovascular complications: a new challenge for emergency physicians. Am J Emerg Med 19 (2001) 566-574
32. Hirsch H.H., Kaufmann G., Sendi P., et al. Immune reconstitution in HIV-infected patients. Clin Infect Dis 38 (2004) 1159-1166
33. Mahrholdt H., Goedecke C., Wagner A., et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 109 (2004) 1250-1258
34. Lipshultz S.E., Orav E.J., Sanders S.P., et al. Immunoglobulins and left ventricular structure and function in pediatrics HIV infection. Circulation 92 (1995) 2220-2225